LivaNova Plc (LIVN)
68.42
+0.53
(+0.78%)
USD |
NASDAQ |
Feb 20, 16:00
68.39
-0.03
(-0.04%)
After-Hours: 20:00
LivaNova SG&A Expense (Quarterly) : 138.52M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| NovoCure Ltd. | 104.47M |
| Abbott Laboratories | 3.129B |
| Alphatec Holdings, Inc. | 124.30M |
| AtriCure, Inc. | 78.34M |
| iRhythm Holdings, Inc. | 122.00M |